When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report

Steroid Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT), or Hashimoto’s encephalopathy, is a rare autoimmune neurological disorder linked to elevated antithyroid antibodies and presenting various neurological symptoms. This report deals with a case of a 54-year-old female wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Palash Kotak, Kashish Khurana, Sarang Raut, Saket Satyasham Toshniwal, Sourya Acharya
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1504967/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576535050059776
author Palash Kotak
Kashish Khurana
Sarang Raut
Saket Satyasham Toshniwal
Sourya Acharya
author_facet Palash Kotak
Kashish Khurana
Sarang Raut
Saket Satyasham Toshniwal
Sourya Acharya
author_sort Palash Kotak
collection DOAJ
description Steroid Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT), or Hashimoto’s encephalopathy, is a rare autoimmune neurological disorder linked to elevated antithyroid antibodies and presenting various neurological symptoms. This report deals with a case of a 54-year-old female with a history of hypothyroidism who presented with hypertensive emergency and atypical neurological symptoms that deteriorated during the hospital stay. On testing, she was euthyroid. Initial investigations, including MRI and CSF analysis, were inconclusive, but high levels of antithyroid peroxidase (Anti TPO) antibodies confirmed the diagnosis of SREAT. The patient was managed with intravenous methylprednisolone, leading to rapid clinical improvement. SREAT, being a diagnosis of exclusion, presents with various neurological and neuropsychiatric symptoms that can be difficult to identify. This condition remains poorly understood, though autoimmune factors and antithyroid antibodies seem to play a role. Glucocorticoids remain the primary treatment choice. At the same time, other immunosuppressive agents are reserved for non-responders. This case highlights the critical importance of early diagnosis in SREAT, as early recognition and corticosteroid treatment can lead to significant recovery. Timely intervention is essential for improved patient prognosis, emphasizing the need for awareness of SREAT in patients with a history of hypothyroidism presenting with neurological symptoms.
format Article
id doaj-art-320c7068fa2f40868eff5431c935b2ba
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-320c7068fa2f40868eff5431c935b2ba2025-01-31T05:10:20ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011610.3389/fimmu.2025.15049671504967When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case reportPalash KotakKashish KhuranaSarang RautSaket Satyasham ToshniwalSourya AcharyaSteroid Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT), or Hashimoto’s encephalopathy, is a rare autoimmune neurological disorder linked to elevated antithyroid antibodies and presenting various neurological symptoms. This report deals with a case of a 54-year-old female with a history of hypothyroidism who presented with hypertensive emergency and atypical neurological symptoms that deteriorated during the hospital stay. On testing, she was euthyroid. Initial investigations, including MRI and CSF analysis, were inconclusive, but high levels of antithyroid peroxidase (Anti TPO) antibodies confirmed the diagnosis of SREAT. The patient was managed with intravenous methylprednisolone, leading to rapid clinical improvement. SREAT, being a diagnosis of exclusion, presents with various neurological and neuropsychiatric symptoms that can be difficult to identify. This condition remains poorly understood, though autoimmune factors and antithyroid antibodies seem to play a role. Glucocorticoids remain the primary treatment choice. At the same time, other immunosuppressive agents are reserved for non-responders. This case highlights the critical importance of early diagnosis in SREAT, as early recognition and corticosteroid treatment can lead to significant recovery. Timely intervention is essential for improved patient prognosis, emphasizing the need for awareness of SREAT in patients with a history of hypothyroidism presenting with neurological symptoms.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1504967/fullSREATHashimoto’s encephalopathyautoimmune encephalopathyantithyroid antibodiescorticosteroids
spellingShingle Palash Kotak
Kashish Khurana
Sarang Raut
Saket Satyasham Toshniwal
Sourya Acharya
When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report
Frontiers in Immunology
SREAT
Hashimoto’s encephalopathy
autoimmune encephalopathy
antithyroid antibodies
corticosteroids
title When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report
title_full When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report
title_fullStr When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report
title_full_unstemmed When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report
title_short When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report
title_sort when thyroid met brain the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report
topic SREAT
Hashimoto’s encephalopathy
autoimmune encephalopathy
antithyroid antibodies
corticosteroids
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1504967/full
work_keys_str_mv AT palashkotak whenthyroidmetbraintheenigmaofsteroidresponsiveencephalopathyassociatedwithautoimmunethyroiditisacasereport
AT kashishkhurana whenthyroidmetbraintheenigmaofsteroidresponsiveencephalopathyassociatedwithautoimmunethyroiditisacasereport
AT sarangraut whenthyroidmetbraintheenigmaofsteroidresponsiveencephalopathyassociatedwithautoimmunethyroiditisacasereport
AT saketsatyashamtoshniwal whenthyroidmetbraintheenigmaofsteroidresponsiveencephalopathyassociatedwithautoimmunethyroiditisacasereport
AT souryaacharya whenthyroidmetbraintheenigmaofsteroidresponsiveencephalopathyassociatedwithautoimmunethyroiditisacasereport